GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Hypoxia, HIF and Tumorigenesis

$265,200
Thomas Jefferson University · R01 · FY2005 · CA

Genome and Single Cell Technologies Shared Resource

$265,191
Mark D Adams · Jackson Laboratory · P30 · FY2024 · CA

Imaging and Identification of Micro-Environments Eliciting Mammary Tumor Cell Mig

$265,128
John S Condeelis · Albert Einstein College Of Medicine, Inc · U54 · FY2015 · CA

Tungsten and Breast Cancer: Impact of the Tumor Microenvironment

$265,125
Alicia M. Bolt · University Of New Mexico Health Scis Ctr · P20 · FY2020 · GM

Multi-Peptide/IL 12 Melanoma Vaccine

$265,071
Thomas F Gajewski · University Of Chicago · R01 · FY2006 · CA

Role of Fibulin-5 in Tumorigenesis and TGF-beta Biology

$265,007
National Jewish Health · R01 · FY2003 · CA

Project 2-Metabolic Modulation of Myeloid-Derived Suppressor Cells to Increase Efficacy of Neo adjuvant Chemotherapy and Immunotherapy

$265,003
Augusto C Ochoa · Lsu Health Sciences Center · P20 · FY2018 · CA

Mechanisms of Immune Suppression in Ovarian Cancer

$264,989
Keith L Knutson · Mayo Clinic Rochester · P50 · FY2011 · CA

DNA Damage Targeted Gene Therapy in Head & Neck Cancer

$264,963
Ralph R Weichselbaum · University Of Chicago · R01 · FY2007 · CA

Partnership to Assess Viral and Immune Landscape Intersections with ONcology for People Living with HIV (PAVILION)

$264,938
Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2025 · CA

Project 1: Modeling the Interface between Non-invasive Imaging and Drug Distribution

$264,879
Kristin R Swanson · Massachusetts Institute Of Technology · U54 · FY2020 · CA

Vascular Maintenance and Brain Tumor Refractory

$264,875
P Charles Lin · Vanderbilt University · R01 · FY2008 · NS

Vascular Maintenance and Brain Tumor Refractory

$264,875
P Charles Lin · Vanderbilt University · R01 · FY2007 · NS

Combinatorial targeting for the treatment of B-cell acute lymphoblastic leukemia

$264,870
Sharan Kumar Reddy Bobbala · West Virginia University · P20 · FY2024 · GM

Improving T Cell Therapies for Nasopharyngeal Cancer

$264,825
Stephen Gottschalk · Baylor College Of Medicine · P01 · FY2013 · CA

LIGHT for the Recognition and Eradication of Advanced Cancer

$264,778
Yang-Xin Fu · University Of Chicago · P01 · FY2012 · CA

Myeloma-Microenvironment Interaction Dynamics

$264,773
Shmuel Yaccoby · Univ Of Arkansas For Med Scis · R01 · FY2008 · CA

In situ antitumor immunity and effects of radiation

$264,770
University Of Rochester · R01 · FY2002 · CA

In situ antitumor immunity and effects of radiation

$264,770
University Of Rochester · R01 · FY2001 · CA

In situ antitumor immunity and effects of radiation

$264,770
University Of Rochester · R01 · FY2003 · CA

In situ antitumor immunity and effects of radiation

$264,770
University Of Rochester · R01 · FY2004 · CA

In situ antitumor immunity and effects of radiation

$264,770
University Of Rochester · R01 · FY2005 · CA

The molecular regulation of IGFBP-3 in esophageal epthelial cells

$264,737
Hiroshi Nakagawa · University Of Pennsylvania · R01 · FY2011 · DK

Early Phase Clinical Trials in Imaging and Image-Guided Interventions

$264,708
Aerang Kim · Children'S Research Institute · R01 · FY2016 · CA

Quantitative High Throughput Screening for Small Molecules Targeting CD47 in Cancer

$264,598
Thomas W Miller · Institut Jean Paoli & Irene Calmettes Centre Regional De Lutte Contre Le Cancer · R37 · FY2023 · CA